Arcus Biosciences Inc banner

Arcus Biosciences Inc
NYSE:RCUS

Watchlist Manager
Arcus Biosciences Inc Logo
Arcus Biosciences Inc
NYSE:RCUS
Watchlist
Price: 25.34 USD 3.51%
Market Cap: $3.2B

Wall St Price Targets

RCUS Price Targets Summary
Arcus Biosciences Inc

Wall Street analysts forecast RCUS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RCUS is 35.14 USD with a low forecast of 22.22 USD and a high forecast of 49.35 USD.

Lowest Forecast
Price Target
22.22 USD
12% Downside
Average Forecast
Price Target
35.14 USD
39% Upside
Highest Forecast
Price Target
49.35 USD
95% Upside
Arcus Biosciences Inc Competitors:
Price Targets
LH6
LHC Group Inc
41% Upside
AMAL
Amalgamated Bank
13% Upside
VYNE
Vyne Therapeutics Inc
199% Upside
INO
Inovio Pharmaceuticals Inc
426% Upside

Revenue
Forecast

91% / Year
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat
91% / Year
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat

Over the last 8 years, the compound annual growth rate for Revenue has been 91%. The projected CAGR for the next 8 years is 36%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-46%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-46%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is RCUS's stock price target?
Price Target
35.14 USD

According to Wall Street analysts, the average 1-year price target for RCUS is 35.14 USD with a low forecast of 22.22 USD and a high forecast of 49.35 USD.

What is the Revenue forecast for Arcus Biosciences Inc?
Projected CAGR
36%

Over the last 8 years, the compound annual growth rate for Revenue has been 91%. The projected CAGR for the next 8 years is 36%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett